Literature DB >> 28471046

A first in human evaluation of a novel contrast media saving device.

James Sapontis1, Garry Barron1, Sujith Seneviratne1, Georg Fuernau2,3, Ingo Eitel2,3, Jakob Ledwoch2,3, Holger Thiele2,3, Mohammed Saad2,3, Suzanne de Waha2,3, Janine Poess2,3, Steffen Desch2,3.   

Abstract

OBJECTIVES: This study evaluated the usability and contrast volume savings of the novel DyeVert™ System.
BACKGROUND: During coronary diagnostic and interventional procedures, a substantial portion of injected contrast does not contribute to vessel imaging due to reflux into the ascending aorta. Contrast volume is the primary physician modifiable risk factor for prevention of contrast-induced acute kidney injury CI-AKI which is a frequent complication in patients undergoing coronary angiographic procedures and is related to increases in morbidity, mortality, and healthcare costs.
METHODS: In this pilot trial, 44 patients undergoing coronary diagnostic and/or percutaneous coronary intervention (PCI) procedures were enrolled in two centers. All procedures were conducted using a manual manifold injection setup and the DyeVert System, which facilitates the diversion of excess contrast volume prior to injection into the patient. Direct measurements of both the amount of contrast that was attempted to be injected and the actual volume injected into the patient were taken.
RESULTS: The difference between the two amounts indicated the volume saved. Procedure types included 34 diagnostic studies and 10 PCI. The mean percent volume saved by the DyeVert System was 47%, with a corresponding P value of <0.0001 achieving the pre-specified level of greater than 15% of contrast media being saved. Mean volume savings were similar for both diagnostic (47 ± 9%) and PCI (50 ± 9%) procedures. Image quality was good in 43/44 (98%) patients.
CONCLUSIONS: The DyeVert System substantially decreases contrast delivered to patients during diagnostic or interventional coronary procedures while maintaining adequate image quality.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  angiographic coronary; contrast agents; percutaneous coronary intervention; renal disease chronic

Mesh:

Substances:

Year:  2017        PMID: 28471046     DOI: 10.1002/ccd.27033

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Early clinical experiences with a novel contrast volume reduction system during invasive coronary angiography.

Authors:  Raphael R Bruno; Amir M Nia; Georg Wolff; Ralf Erkens; Malte Kelm; Ralf Westenfeld; Christian Jung
Journal:  Int J Cardiol Heart Vasc       Date:  2019-05-15

2.  A prospective study of contrast preservation using ultra-low contrast delivery technique versus standard automated contrast injector system in coronary procedures.

Authors:  Adam Stys; Maheedhar Gedela; Udit Bhatnagar; Marian Petrasko; Hazem Dawoud; Tadeusz Malinski; Tomasz Stys
Journal:  Indian Heart J       Date:  2019-09-10

3.  DyeVert Contrast Reduction System Use in Patients Undergoing Coronary and/or Peripheral Angiography: A Systematic Literature Review and Meta-Analysis.

Authors:  Giuseppe Tarantini; Anand Prasad; Sudhir Rathore; Shweta Bansal; Regine Gottfried; Alexander R Rosenkranz; Carlo Briguori; Mohsen Yaghoubi; Atefeh Mashayekhi; Mehdi Javanbakht; Eoin Moloney
Journal:  Front Med (Lausanne)       Date:  2022-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.